Kevin Cavanagh

881 total citations
21 papers, 650 citations indexed

About

Kevin Cavanagh is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Kevin Cavanagh has authored 21 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Kevin Cavanagh's work include Lysosomal Storage Disorders Research (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Carbohydrate Chemistry and Synthesis (6 papers). Kevin Cavanagh is often cited by papers focused on Lysosomal Storage Disorders Research (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Carbohydrate Chemistry and Synthesis (6 papers). Kevin Cavanagh collaborates with scholars based in United States, Australia and Canada. Kevin Cavanagh's co-authors include Joel T. Nigg, Molly A. Nikolas, Karen H. Friderici, Wilfried Karmaus, Michelle M. Martel, Marsha D. Rappley, M. Z. Jones, Jeffrey R. Leipprandt, John J. Hopwood and Joseph Alroy and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biological Psychiatry.

In The Last Decade

Kevin Cavanagh

21 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Cavanagh United States 11 238 180 137 105 86 21 650
Michael Nester Saudi Arabia 18 205 0.9× 105 0.6× 18 0.1× 296 2.8× 74 0.9× 27 904
Xiaogang Yu China 14 194 0.8× 67 0.4× 19 0.1× 115 1.1× 138 1.6× 60 689
Domingo J. Piñero United States 14 82 0.3× 143 0.8× 78 0.6× 148 1.4× 390 4.5× 20 1.1k
Claudia Casalini Italy 15 74 0.3× 47 0.3× 94 0.7× 112 1.1× 26 0.3× 31 694
Hoa H. Le United States 13 542 2.3× 32 0.2× 115 0.8× 169 1.6× 12 0.1× 43 1.2k
Charles J. Ganley United States 7 129 0.5× 122 0.7× 66 0.5× 59 0.6× 5 0.1× 10 612
Stephanie J.B. Fretham United States 13 152 0.6× 79 0.4× 29 0.2× 150 1.4× 272 3.2× 15 878
Oduvaldo Câmara Marques Pereira Brazil 18 100 0.4× 63 0.3× 20 0.1× 126 1.2× 37 0.4× 54 852
Emily W. Y. Tung Canada 11 164 0.7× 38 0.2× 34 0.2× 211 2.0× 24 0.3× 13 522
J. Buschmann Germany 14 169 0.7× 35 0.2× 15 0.1× 134 1.3× 24 0.3× 31 686

Countries citing papers authored by Kevin Cavanagh

Since Specialization
Citations

This map shows the geographic impact of Kevin Cavanagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Cavanagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Cavanagh more than expected).

Fields of papers citing papers by Kevin Cavanagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Cavanagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Cavanagh. The network helps show where Kevin Cavanagh may publish in the future.

Co-authorship network of co-authors of Kevin Cavanagh

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Cavanagh. A scholar is included among the top collaborators of Kevin Cavanagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Cavanagh. Kevin Cavanagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Miriam N., Kevin Cavanagh, Christophe Chesné, et al.. (2023). OECD workshop consensus report: Ethical considerations with respect to human derived products, specifically human serum, in OECD test guidelines. SHILAP Revista de lepidopterología. 5. 1140698–1140698. 8 indexed citations
2.
Tierce, Millard L., Karen Andruszewski, Kevin Cavanagh, et al.. (2013). TREC <30 in Infants without SCID As A Marker for High Mortality. Journal of Allergy and Clinical Immunology. 131(2). AB73–AB73. 1 indexed citations
3.
Korzeniewski, Steven J., Kevin Cavanagh, Samya Z. Nasr, et al.. (2010). Variation in immunoreactive trypsinogen concentrations among michigan newborns and implications for cystic fibrosis newborn screening. Pediatric Pulmonology. 46(2). 125–130. 19 indexed citations
4.
5.
Nigg, Joel T., Michelle M. Martel, Molly A. Nikolas, et al.. (2007). Low Blood Lead Levels Associated with Clinically Diagnosed Attention-Deficit/Hyperactivity Disorder and Mediated by Weak Cognitive Control. Biological Psychiatry. 63(3). 325–331. 205 indexed citations
6.
Jones, M. Z., Joseph Alroy, Erinn Downs‐Kelly, et al.. (2004). Caprine Mucopolysaccharidosis IIID: Fetal and Neonatal Brain and Liver Glycosaminoglycan and Morphological Perturbations. Journal of Molecular Neuroscience. 24(2). 277–292. 9 indexed citations
7.
Downs‐Kelly, Erinn, M. Z. Jones, Joseph Alroy, et al.. (2000). Caprine Mucopolysaccharidosis IIID: A Preliminary Trial of Enzyme Replacement Therapy. Journal of Molecular Neuroscience. 15(3). 251–262. 21 indexed citations
8.
Artiss, Joseph D., Raymond E. Karcher, Kevin Cavanagh, et al.. (2000). A Liquid-Stable Reagent for Lactic Acid Lsevels. American Journal of Clinical Pathology. 114(1). 139–143. 28 indexed citations
9.
Jones, M. Z., Joseph Alroy, Philip J. Boyer, et al.. (1998). Caprine Mucopolysaccharidosis-IIID. Journal of Neuropathology & Experimental Neurology. 57(2). 148–157. 30 indexed citations
10.
Hoard-Fruchey, Heidi M., et al.. (1998). Determination of Genotypic Frequency of Caprine Mucopolysaccharidosis IIID. Journal of Veterinary Diagnostic Investigation. 10(2). 181–183. 5 indexed citations
11.
Jones, M. Z., Joseph Alroy, John W. Taylor, et al.. (1997). Human Mucopolysaccharidosis IIID. Journal of Neuropathology & Experimental Neurology. 56(10). 1158–1167. 58 indexed citations
12.
13.
Friderici, Karen H., Kevin Cavanagh, Jeffrey R. Leipprandt, et al.. (1995). Cloning and sequence analysis of caprine N-acetylglucosamine 6-sulfatase cDNA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1271(2-3). 369–373. 18 indexed citations
14.
Chen, Hong, Jeffrey R. Leipprandt, Bryce L. Sopher, et al.. (1995). Molecular Cloning and Characterization of Bovine β-Mannosidase. Journal of Biological Chemistry. 270(8). 3841–3848. 29 indexed citations
15.
Lovell, Kathryn L., et al.. (1994). Biochemical and histochemical analysis of lysosomal enzyme activities in caprine β-mannosidosis. Molecular and Chemical Neuropathology. 21(1). 61–74. 11 indexed citations
16.
Dunstan, Robert W., Kevin Cavanagh, & M. Z. Jones. (1983). Caprine α- and β-mannosidase activities: Effects of age, sex, and reproductive status and potential use in heterozygote detection of β-mannosidosis. American Journal of Veterinary Research. 44(4). 685–689. 3 indexed citations
17.
Cavanagh, Kevin, Robert W. Dunstan, & M. Z. Jones. (1983). Measurement of caprine plasma β-mannosidase with a p-nitrophenyl substrate. American Journal of Veterinary Research. 44(4). 681–684. 1 indexed citations
18.
Cavanagh, Kevin, Robert W. Dunstan, & M. Z. Jones. (1982). Plasma α- and β-mannosidase activities in caprine β-mannosidosis. American Journal of Veterinary Research. 43(6). 1058–1059. 8 indexed citations
19.
Cavanagh, Kevin, et al.. (1981). Multiple forms of bovine kidney alkaline phosphatase. Clinical Biochemistry. 14(3). 150–152. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Nester Breakdown of academic impact, for papers by Xiaogang Yu Breakdown of academic impact, for papers by Domingo J. Piñero Breakdown of academic impact, for papers by Claudia Casalini Breakdown of academic impact, for papers by Hoa H. Le Breakdown of academic impact, for papers by Charles J. Ganley Breakdown of academic impact, for papers by Stephanie J.B. Fretham Breakdown of academic impact, for papers by Oduvaldo Câmara Marques Pereira Breakdown of academic impact, for papers by Emily W. Y. Tung Breakdown of academic impact, for papers by J. Buschmann
Rankless by CCL
2026